Latest Class Actions News

EQT Holdings Limited reported a robust 60% increase in net profit after tax for FY25, completing a strategic transformation while navigating significant regulatory challenges. The company outlined a growth-focused strategy for FY26, emphasizing digital innovation and margin improvement.

Triangle Energy has initiated legal proceedings against Strike Energy's subsidiary over a $3.84 million dispute tied to the L7 permit in the Perth Basin, escalating tensions in a key oil and gas project.

Australian authorities have executed a search warrant at WiseTech Global's Sydney office amid an investigation into alleged insider trading involving the company's founder and employees. No charges have been filed, and the company pledges full cooperation.

PT Aneka Tambang Tbk (ANTAM) reports robust nine-month 2025 financial results with significant profit growth, while navigating complex legal disputes and evolving mining regulations.

Newmont Corporation reported a strong third quarter in 2025, driven by higher gold prices and successful divestitures of non-core assets, enhancing liquidity and reducing debt. The company’s operational shifts and cost management reflect a strategic pivot in a volatile market.

Phoslock Environmental Technologies reported a $952,000 operating cashflow deficit in Q3 2025 amid rising legal and logistics expenses, while sales volumes improved and production is set to resume in early 2026.

Zuleika Gold has locked in $5 million in funding to boost exploration efforts and strengthen its financial footing in Western Australia's prolific gold belt.

Structural Monitoring Systems Plc faces a high-stakes legal battle as CEO Ross Love and Turton House Group initiate Federal Court proceedings alleging adverse action and whistleblower victimisation.

AMP Limited reports a 3.6% rise in total assets under management, driven by a 61.6% jump in Platforms net cashflows and steady growth across divisions, alongside significant legal settlements.

Findi Limited has responded to ASX inquiries about unusual stock price and volume movements, denying any undisclosed information and announcing legal action against a former subsidiary executive for misleading social media posts.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

Cyclopharm Ltd has been hit with legal proceedings by 4D Medical Limited, accusing it of making false and misleading statements during a March webinar. Cyclopharm denies the allegations, calling the claim without merit.